You have 9 free searches left this month | to do more
Showing 1 - 25 of
596 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Active, not recruiting
  • Multiple Myeloma
  • RP followed by MPR
  • (no location specified)
2022-03-24
Mar 24, 2022
C
Active, not recruiting
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
2022-01-12
Jan 12, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
W
Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
N
Recruiting
  • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
  • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Completed
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-02-10
Feb 10, 2021
U
Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
2022-02-09
Feb 9, 2022
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-09-02
Sep 2, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
O
Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
2021-10-18
Oct 18, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • KRdD followed by auto-HCT
  • KRdD only
  • Birmingham, Alabama
  • +3 more
2022-03-26
Mar 26, 2022
W
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2022-02-01
Feb 1, 2022
U
Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
2021-06-07
Jun 7, 2021
B
Active, not recruiting
  • B Cell Lymphoma
  • Lymphoma
  • Cleveland, Ohio
  • +1 more
2022-03-03
Mar 3, 2022
F
Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
2021-11-22
Nov 22, 2021
T
Completed
  • Follicular Lymphoma
  • Lenalidomide and R-CHOP
  • Bordeaux, France
  • +23 more
2021-07-23
Jul 23, 2021
J
Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
2022-03-03
Mar 3, 2022
D
Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-02-11
Feb 11, 2022
U
Active, not recruiting
  • Lymphoma
  • Sacramento, California
    University of California Davis Cancer Center
2021-11-15
Nov 15, 2021
W
Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
2021-10-29
Oct 29, 2021
U
Recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-11-26
Nov 26, 2021
D
Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-03-15
Mar 15, 2022